Detalhe da pesquisa
1.
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy.
Eur J Haematol
; 106(4): 574-583, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512026